News News Select Year All Years 2026 (18) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 490 Results Page 13 of 49« First«...1112131415...203040...»Last » September 7, 2022 DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut-Allergic Children Ages 4 to 7 Years September 2, 2022 DBV Technologies to Present at Upcoming Investor Conferences August 1, 2022 DBV Technologies Reports Second Quarter 2022 Financial Results July 27, 2022 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF June 29, 2022 DBV Technologies to Participate in Upcoming EAACI 2022 Congress June 16, 2022 DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York June 9, 2022 DBV Technologies Announces Private Placement Financing of $194 Million June 7, 2022 DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut- Allergic Toddlers May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting May 5, 2022 DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its At-The-Market program (ATM) Page 13 of 49« First«...1112131415...203040...»Last »
